24/7 Market News Snapshot 18 November, 2024 – Sensus Healthcare, Inc (NASDAQ:SRTS)

November 18, 2024

DENVER, Colo., 18 November, 2024 (247marketnews.com) – (NASDAQ:SRTS) are discussed in this article.
Sensus Healthcare, Inc. (SRTS) has recently experienced a notable increase in stock trading, reflecting strong investor interest and engagement. The stock opened at $7.69 and is currently trading at approximately $8.426, marking a gain of around 10.29% from the prior close of $7.640. This uptick is accompanied by a trading volume of 877.14K, indicating active participation in the market. Traders are advised to monitor technical indicators for potential bullish momentum and watch for resistance levels around recent highs, as market sentiment continues to drive the stock upward.

In parallel, Sensus Healthcare has disclosed impressive financial results for the third quarter of 2024. Revenues reached $8.8 million, a significant increase of 127% compared to $3.9 million in the same quarter of the previous year, primarily driven by the rising demand for its superficial radiotherapy (SRT) units. In this quarter, the company shipped 27 systems, bolstering its market position in non-invasive treatment options for oncological and non-oncological skin conditions.

Moreover, Sensus Healthcare reported a net income of $1.2 million, or $0.07 per diluted share, recovering from a net loss of $1.5 million a year earlier. Adjusted EBITDA rose to $1.6 million, a substantial improvement from a negative $1.7 million recorded in the previous year. The company ended the quarter with a robust cash position of $22.6 million and no outstanding debt.

Sensus Healthcare’s Fair Deal Agreements program, aimed at easing financial barriers for customers, has seen 22 agreements since its launch, with expectations to surpass 50 IG-SRT Systems under contract by year-end. The CEO, Joe Sardano, credits the increased traction for SRT treatments to the innovative Sentinel IT software, enhancing clinical billing efficiency and facilitating real-time equipment usage tracking.

With a growing customer base and a commitment to innovative treatment solutions, Sensus Healthcare is strategically positioned for continued growth and an expanding role in the skin cancer treatment market.

Related news for (SRTS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.